The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
23688558 |
37 |
Antagonism of L-type Ca2+ channels CaV1.3 and CaV1.2 by 1,4-dihydropyrimidines and 4H-pyrans as dihydropyridine mimics.![EBI](/images/logo_chembl.png) |
Northwestern University |
23651412 |
90 |
Structure-activity relationship of N,N'-disubstituted pyrimidinetriones as Ca(V)1.3 calcium channel-selective antagonists for Parkinson's disease.![EBI](/images/logo_chembl.png) |
Northwestern University |
1377748 |
16 |
Synthesis of 3-[(2,3-dihydro-1,1,3-trioxo-1,2-benzisothiazol-2-yl)alkyl] 1,4-dihydropyridine-3,5-dicarboxylate derivatives as calcium channel modulators.![EBI](/images/logo_chembl.png) |
Alter |
3184128 |
22 |
Synthesis of (aryloxy)alkylamines. 2. Novel imidazo-fused heterocycles with calcium channel blocking and local anesthetic activity.![EBI](/images/logo_chembl.png) |
Ortho Pharmaceutical |
20382537 |
138 |
Antagonism of 4-substituted 1,4-dihydropyridine-3,5-dicarboxylates toward voltage-dependent L-type Ca2+ channels Ca V 1.3 and Ca V 1.2.![EBI](/images/logo_chembl.png) |
Northwestern University |
2435903 |
4 |
Synthesis and biological activity of novel calcium channel blockers: 2,5-dihydro-4-methyl-2-phenyl-1,5-benzothiazepine-3-carboxylic acid esters and 2,5-dihydro-4-methyl-2-phenyl-1,5-benzodiazepine-3-carboxylic acid esters.![EBI](/images/logo_chembl.png) |
TBA |